Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
11/2009
11/18/2009EP2118099A2 Process for the synthesis of 2-aminothiazole compounds as kinase inhibitors
11/18/2009EP2118098A2 Polymorphic forms of a macrocyclic inhibitor of hcv
11/18/2009EP2118093A1 [1,2,3]triazolyl substituted quinolines and coumarins as inhibitors of leukotriene biosynthesis
11/18/2009EP2118088A1 Heterocyclic compounds and their use in treating inflammation, angiogenesis and cancer
11/18/2009EP2117540A1 New use of glutaminyl cyclase inhibitors
11/18/2009EP2117311A1 Therapeutic agents
11/18/2009EP2018367B1 Novel microbiocides
11/18/2009EP2003975B1 3-amino-1,2-benzisothiazole compounds for combating animal pest
11/18/2009EP1893609B1 N-(pyridin-2-yl)-sulfonamide derivatives
11/18/2009EP1442026B9 Triazole derivatives as cyclooxygenase (cox) inhibitors
11/18/2009EP1218354B1 Quinazoline derivatives and their use as pharmaceuticals
11/18/2009CN101583597A Sulfonamide derivatives as liver carnitine palmitoyl transferase (L-CPT1)
11/18/2009CN101583365A Triazine derivatives and their therapeutical applications
11/18/2009CN101580489A Nitrogenous heterocyclic ring compound and preparation method and application thereof
11/18/2009CN100560584C Benzoazolypiperazine derivatives having MGLUR1- and MGLUR5-antagonistic activity
11/18/2009CN100560566C Benzyloxy derivatives as MAOB inhibitors
11/17/2009US7619094 Ketoamides with cyclic P4's as inhibitors of NS3 serine protease of hepatitis C virus
11/17/2009US7619092 Such as (2R,4S)-1-{N-(3,5-bistrifluoromethylbenzyl)-N-methyl}-aminocarbonyl-2-(4-fluoro-2-methylphenyl)-4-(2-hydroxyethoxy)-piperidine; tachykinin receptor antagonists
11/17/2009US7619091 Treating nervous system disorders such as mild cognitive impairment, Alzheimer's disease or dementia associated with Down syndrome; e.g. use of 5,7-dichloro-8-hydroxy-2-(2-pyridyl)-quinoline (PBT 1052)
11/17/2009US7618975 4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis; antiproliferative, anticarcinogenic, antimetabolic agents; tubulin and topoisomerase II inhibitors; fungicides; synergistic administration with other anticarcinogenic agents
11/17/2009US7618961 A sulfonylamino-tetrahydro(1,3)thiazolo(5,4-c)pyridinyl or benzothiazole derivatives, for treating diabetes, syndrome X, obesity, glaucoma, hyperlipidemia, hyperglycemia, hyperinsulinemia, osteoporosis, tuberculosis, dementia
11/17/2009CA2521950C Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
11/17/2009CA2510949C Polymorph of ritonavir
11/17/2009CA2470519C Heteroaryl substituted pyrrole modulators of metabotropic glutamate receptor-5
11/17/2009CA2463272C Piperazine derivatives with ccr1 receptor antagonist activity
11/17/2009CA2422925C .delta.1-pyrrolines used as pesticides
11/17/2009CA2382296C Selective cox-2 inhibitory novel esters from indolealkanols and novel amides from indolealkylamines
11/17/2009CA2374158C Indole derivatives
11/17/2009CA2352494C Compositions and methods for the treatment of alzheimer's disease, central nervous system injury, and inflammatory diseases
11/17/2009CA2272460C Pyridin-2-yl-methylamine derivatives, method of preparing and application as medicine
11/12/2009WO2009137596A1 Substituted amides, method of making, and use as btk inhibitors
11/12/2009WO2009137538A2 Fungicidal substituted azoles
11/12/2009WO2009137500A1 6-substituted benzofuran compounds to treat infection with hepatitis c virus
11/12/2009WO2009137411A1 Therapeutic compounds
11/12/2009WO2009137404A1 Urea compounds as gamma secretase modulators
11/12/2009WO2009137391A2 Benzene sulfonamide thiazole and oxazole compounds
11/12/2009WO2009137338A1 Pyrazole compounds as ccr1 antagonists
11/12/2009WO2009137081A2 Small molecule inhibitors of plasmodium falciparum dihydroorotate dehydrogenase
11/12/2009WO2009136995A2 Inhibitors of syk protein kinase
11/12/2009WO2009136191A1 Chemical compounds
11/12/2009WO2009136175A1 Compounds for use in stabilizing p53 mutants
11/12/2009WO2009135299A1 3, 4 - substituted piperidine derivatives as renin inhibitors
11/12/2009WO2008133344A3 Piperidine derivative and use thereof
11/12/2009WO2007084435A8 Methods for treating hepatitis c
11/12/2009US20090281336 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
11/12/2009US20090281324 Processes for the preparation of o-[5-(4-amino-thiazol-2-yl)-pyridin-2-ylmethyl]-hydroxylamine
11/12/2009US20090281321 Exo- and diastereo- selective syntheses of himbacine analogs
11/12/2009US20090281310 Cinnamide compound
11/12/2009US20090281308 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
11/12/2009US20090281293 Processes for the preparation of 2 fluoro 6-11 bicyclic erythromycin derivatives
11/12/2009US20090281152 Indole Compounds Having Affinity to the EP1 Receptor
11/12/2009US20090281142 Thiazole derivative
11/12/2009US20090281095 Thiomorpholine compound and process for preparing the same
11/12/2009US20090281094 Derivatives of 1--4-methylpiperazine, synthesis process and uses thereof
11/12/2009US20090281089 Pyridyl inhibitors of hedgehog signalling
11/12/2009US20090281072 Diaminopyrimidinecarboxamide Derivative
11/12/2009US20090281060 Heterocyclic derivatives as gpcr receptor agonists
11/12/2009US20090280192 Method for treating or preventing alzheimer's disease
11/12/2009US20090280083 Compounds for the Treatment of Hepatitis C
11/12/2009CA2728893A1 Inhibitors of syk protein kinase
11/12/2009CA2723893A1 Therapeutic n-aryl or n-heteroaryl pyrazolidine and pyrazolidinone derivatives
11/12/2009CA2723431A1 Nip thiazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
11/12/2009CA2723396A1 Benzene sulfonamide thiazole and oxazole compounds
11/12/2009CA2723237A1 Substituted amides, method of making, and use as btk inhibitors
11/12/2009CA2722811A1 Pyrazole compounds as ccr1 antagonists
11/12/2009CA2722734A1 3,4-substituted piperidine derivatives as renin inhibitors
11/12/2009CA2722606A1 Urea compounds as gamma secretase modulators
11/11/2009EP2116541A1 Proline derivatives and their use as dipeptidyl peptidase IV inhibitors
11/11/2009EP2116530A1 Novel pyrrole derivative having ureide group and aminocarbonyl group as substituents
11/11/2009EP2114937A1 Phenothiazin derivates, method for the production thereof and use thereof as pharmaceuticals
11/11/2009EP2114917A2 Pyrrole compounds
11/11/2009EP2114902A2 Hiv inhibiting 5,6-substituted pyrimidines
11/11/2009EP2114901A1 Hiv inhibiting 6-substituted pyrimidines
11/11/2009EP2114900A1 Thiopyrimidine-based compounds and uses thereof
11/11/2009EP2114410A2 N-amino tetrahydrothiazine derivatives, method of manufacture and use
11/11/2009EP1928508B1 Biotin diaminoderivatives and their conjugates with macrocyclic chelating agents
11/11/2009EP1917246B1 Benzoquinazoline derivatives and their use in treating bone disorders
11/11/2009EP1874745B1 New 3-phenylpropionic acid derivatives and their use as ppar- gamma receptor ligands
11/11/2009EP1833816B1 Substituted piperidines as renin inhibitors
11/11/2009EP1713823B1 Hcv ns-3 serine protease inhibitors
11/11/2009EP1606255B1 Cyclic derivatives as modulators of chemokine receptor activity
11/11/2009EP1492487B1 Mitotic kinesin inhibitors
11/11/2009EP1477186B1 Antipruritics
11/11/2009EP1401451B1 Quinazoline derivatives which promote the release of parathyroid hormone
11/11/2009CN101578283A Crystalline forms of thiazolidinedione derivative and its manufacturing method
11/11/2009CN101578278A Substituted 1-(azolin-2-yl)-amino-1,2-heterocyclyl-ethane compounds for combating pests
11/11/2009CN101578275A Anilinopiperazine derivatives and methods of use thereof
11/11/2009CN101575336A N-aryl piperazine derivative and preparation method thereof and drug composition adopting N-aryl piperazine derivative as active ingredient
11/11/2009CN101575320A Water-soluble triazole antifungal compound
11/11/2009CN100558724C Sulphonic acid amide for regulating bast peptide activity and derivative thereof
11/11/2009CN100558717C Novel medicine
11/11/2009CN100558428C Calcitonin gene related peptide receptor antagonists
11/11/2009CN100558365C Conjugated anti-psychotic drugs and uses thereof
11/11/2009CN100558356C Method of using benzenesulphoamides that are cyclooxygenase-2-inhibitors in the treatment and prevention of neoplasia
11/11/2009CN100558355C Indol-5 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators
11/10/2009US7615570 Antagonists to the vanilloid receptor subtype 1 (VR1) and uses thereof
11/10/2009US7615568 3-[2-(cis-4-aminocyclohexyloxy)-4-methylsulfonylbenzoyl-amino]-N-(5-chloropyridin-2-yl)pyridine-2-carboxamide,; anticoagulant; platelet glycoprotein receptor antagonist; thrombosis; orally; acylation of amino-pyridine by (methylthio)benzoic acid followed by oxidation, alkylation, carbonylation
11/10/2009US7615563 Compositions useful as inhibitors of voltage-gated sodium channels
11/10/2009US7615555 Piperidine derivatives as modulators of chemokine receptor CCR5
11/10/2009CA2491632C Pyrimidinylaminobenzamide derivatives and their use as inhibitors of tyrosine kinases
1 ... 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 ... 628